```html

Episodic Migraine Headache

What is Episodic migraine headache?

A migraine is a neuro‑vascular headache disorder that produces moderate to severe, throbbing pain—often on one side of the head—accompanied by a constellation of sensory and autonomic symptoms. When the attacks occur on fewer than 15 days per month, the condition is classified as **episodic migraine** (as opposed to chronic migraine, which is ≥15 days/month). According to the International Classification of Headache Disorders (ICHD‑3), an episodic migraine attack typically lasts 4–72 hours if untreated, has at least two of the following features, and may be preceded by an aura.

• Unilateral location
• Pulsating quality
• Moderate or severe intensity
• Aggravation by routine physical activity (e.g., walking, climbing stairs)

Episodes may be triggered by hormonal changes, diet, stress, sleep disturbances, or environmental factors. While migraines affect roughly 12 % of the U.S. population, women are three times more likely than men to experience them (Mayo Clinic, 2023).

Common Causes

Unlike a single “cause,” episodic migraines result from a complex interaction of genetic susceptibility and external triggers. Below are 8–10 of the most frequently identified contributors.

• Genetic predisposition: Family history accounts for up to 60 % of migraine risk (NIH, 2022).
• Hormonal fluctuations: Estrogen drops during menstruation, pregnancy, or menopause can precipitate attacks.
• Dietary triggers: Aged cheeses, processed meats (nitrates), alcohol (especially red wine), aspartame, and excessive caffeine.
• Sleep disturbances: Both too little sleep and oversleeping are common precipitants.
• Stress and emotional changes: Acute stress, anxiety, or sudden relief after stress (the “weekend headache”).
• Environmental factors: Bright or flickering lights, loud noises, strong odors, and changes in barometric pressure.
• Medication overuse: Regular use of analgesics or triptans can lead to rebound headaches, converting episodic migraines into a chronic pattern.
• Dehydration & electrolyte imbalance: Inadequate fluid intake or excessive alcohol can lower the pain threshold.
• Physical exertion: Strenuous exercise or sexual activity can trigger an attack in susceptible individuals.
• Other medical conditions: Thyroid disease, hypertension, and sleep apnea are associated with higher migraine frequency.

Associated Symptoms

During a migraine attack, patients often experience a range of sensory, autonomic, and neurological symptoms. Commonly reported features include:

• Aura: Visual disturbances (flashing lights, zig‑zag lines), sensory tingling, or speech difficulty, lasting 5–60 minutes.
• Nausea and vomiting
• Photophobia: Heightened sensitivity to light.
• Phonophobia: Heightened sensitivity to sound.
• Osmophobia: Strong aversion to odors.
• Neck stiffness or tension
• Fatigue or a “migraine hangover” that can last 24 hours after pain resolves.

When to See a Doctor

Most episodic migraines can be managed with lifestyle changes and over‑the‑counter medication, but medical evaluation is warranted when any of the following occur:

• Headache is new, sudden, or markedly different from previous migraines.
• Pain is severe enough to wake you from sleep or interferes with daily functioning.
• Headache lasts longer than 72 hours despite treatment.
• Neurological deficits appear (weakness, vision loss, difficulty speaking).
• Headache follows a head injury or after a recent infection.
• You require increasing amounts of medication to achieve relief (possible medication‑overuse headache).
• You are pregnant, have cardiovascular disease, or are on blood‑thinners and need guidance on safe acute therapy.

Diagnosis

Diagnosing episodic migraine is primarily clinical. A thorough history and physical exam are essential, and imaging is reserved for atypical presentations.

Step‑by‑step evaluation

1. Detailed headache history: Frequency, duration, location, quality, aggravating/relieving factors, associated symptoms, and triggers.
2. Medical and family history: Look for genetic predisposition and comorbid conditions (e.g., depression, hypertension).
3. Review of systems: To screen for red‑flag features (see Emergency Warning Signs).
4. Physical and neurological exam: Usually normal in migraine, but helps exclude other causes.
5. Diagnostic criteria: Apply ICHD‑3 standards (at least 5 attacks fulfilling specific features).
6. Imaging: MRI or CT is ordered only if there are atypical signs such as progressive worsening, focal deficits, or onset after age 50.
7. Laboratory tests: Rarely needed, but a basic metabolic panel may rule out electrolyte disturbances or anemia.

Treatment Options

Therapy for episodic migraine has two goals: aborting an acute attack and preventing future episodes. Treatment is individualized based on attack frequency, severity, comorbidities, and patient preference.

Acute (abortive) treatments

• Non‑prescription analgesics: Ibuprofen 400‑600 mg, naproxen 500 mg, or acetaminophen‑codeine combinations. Take at the first sign of pain.
• Triptans: Sumatriptan, rizatriptan, zolmitriptan, etc. Most effective when administered early; contraindicated in uncontrolled hypertension or coronary disease (Mayo Clinic, 2023).
• Ergots: Dihydroergotamine nasal spray or IV for patients who cannot use triptans.
• Anti‑nausea agents: Metoclopramide or prochlorperazine help with associated vomiting.
• Gepants (CGRP antagonists): Rimegepant and ubrogepant are newer oral options with fewer cardiovascular risks.
• Ditans: Lasmiditan, a serotonin 5‑HT1F agonist, useful for patients with vascular disease.

Preventive (prophylactic) treatments

Considered when migraines occur ≥4 days/month, cause significant disability, or when acute meds are overused.

• First‑line oral meds: Beta‑blockers (propranolol, metoprolol), antiepileptics (topiramate, valproate), and tricyclic antidepressants (amitriptyline).
• CGRP monoclonal antibodies: Erenumab, fremanezumab, galcanezumab – administered monthly or quarterly via subcutaneous injection.
• Onabotulinum toxin A: FDA‑approved for chronic migraine; may benefit high‑frequency episodic migraine.
• Lifestyle & supplements: Magnesium 400‑600 mg daily, riboflavin 400 mg, and coenzyme Q10 100‑300 mg have modest evidence for reduction in attack frequency.

Home and non‑pharmacologic measures

• Cold or warm compresses over the temples or neck.
• Dark, quiet environment to reduce photophobia and phonophobia.
• Hydration: Aim for ≥ 2 L water daily.
• Regular sleep schedule: 7–9 hours, same bedtime/wake‑time.
• Relaxation techniques: Progressive muscle relaxation, guided imagery, or mindfulness meditation.
• Physical activity: Moderate aerobic exercise (e.g., brisk walking) most days, avoiding sudden intense bursts during an attack.

Prevention Tips

Prevention focuses on identifying and modifying triggers, establishing healthy habits, and, when needed, using prophylactic medication.

• Keep a headache diary: Record date, time, foods, stressors, sleep, menstrual cycle, and medication use. Patterns become easier to spot.
• Maintain consistent meal times: Skipping meals can precipitate attacks.
• Limit caffeine: No more than 200 mg/day (≈2 cups coffee) and avoid abrupt withdrawal.
• Stay hydrated: Dehydration is a common trigger.
• Exercise regularly: 30 minutes of moderate activity most days reduces frequency by up to 20 % (Cleveland Clinic, 2023).
• Stress management: CBT, yoga, or biofeedback have demonstrated efficacy in migraine prevention.
• Address hormonal influences: For menstrual migraine, discuss hormonal therapy or short‑course NSAIDs with a clinician.
• Avoid medication overuse: Limit triptan/NSAID use to ≤10 days/month; otherwise risk rebound headaches.
• Screen for comorbidities: Treating sleep apnea, depression, or hypertension can improve migraine control.

Emergency Warning Signs

Key Take‑aways

• Episodic migraine is defined by <15 headache days per month, with typical throbbing, unilateral pain and sensory symptoms.
• Genetics, hormonal shifts, diet, sleep, stress, and certain medications are common triggers.
• Acute treatment includes NSAIDs, triptans, newer CGRP antagonists, and supportive measures.
• Preventive strategies—both pharmacologic (beta‑blockers, CGRP antibodies) and lifestyle‑based—can drastically reduce attack frequency.
• Red‑flag symptoms require urgent evaluation to rule out life‑threatening causes.

For personalized management, consult a neurologist or a headache‑specialty clinic. Early, appropriate therapy can improve quality of life and reduce the risk of progression to chronic migraine.

---

References: Mayo Clinic. Migraine overview. 2023; CDC. Headache and migraine surveillance; NIH. Genetics of migraine; WHO. Global burden of disease 2021; Cleveland Clinic. Migraine treatment guidelines 2023; American Headache Society. Revised treatment recommendations 2022. ```